169 related articles for article (PubMed ID: 24372004)
21. The associations of genetic polymorphisms in CYP1A2 and CYP3A4 with clinical outcomes of breast cancer patients in northern China.
Bai X; Xie J; Sun S; Zhang X; Jiang Y; Pang D
Oncotarget; 2017 Jun; 8(24):38367-38377. PubMed ID: 28418906
[TBL] [Abstract][Full Text] [Related]
22. Cytochrome P450 2D6*10 genotype affects the pharmacokinetics of dimemorfan in healthy Chinese subjects.
Pei Q; Peng J; Tan H; Yang L; Yang X; Liu L; Liu S; Yuan H; Yang G
Eur J Drug Metab Pharmacokinet; 2015 Dec; 40(4):427-33. PubMed ID: 25159483
[TBL] [Abstract][Full Text] [Related]
23. CYP3A4∗18B and CYP3A5∗3 polymorphisms contribute to pharmacokinetic variability of cyclosporine among healthy Chinese subjects.
Tao XR; Xia XY; Zhang J; Tong LY; Zhang W; Zhou X; Liu ZH; Song HT
Eur J Pharm Sci; 2015 Aug; 76():238-44. PubMed ID: 25976223
[TBL] [Abstract][Full Text] [Related]
24. Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers.
He J; Qiu Z; Li N; Yu Y; Lu Y; Han D; Li T; Zhao D; Sun W; Fang F; Zheng J; Fan H; Chen X
Eur J Clin Pharmacol; 2011 Jul; 67(7):701-7. PubMed ID: 21327909
[TBL] [Abstract][Full Text] [Related]
25. CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine.
Lin KM; Tsou HH; Tsai IJ; Hsiao MC; Hsiao CF; Liu CY; Shen WW; Tang HS; Fang CK; Wu CS; Lu SC; Kuo HW; Liu SC; Chan HW; Hsu YT; Tian JN; Liu YL
Pharmacogenomics; 2010 Nov; 11(11):1535-43. PubMed ID: 21121774
[TBL] [Abstract][Full Text] [Related]
26. G-2964A and C734A genetic polymorphisms of CYP1A2 in Chinese population.
Han XM; Chen XP; Wu QN; Jiang CH; Zhou HH
Acta Pharmacol Sin; 2000 Nov; 21(11):1031-4. PubMed ID: 11501059
[TBL] [Abstract][Full Text] [Related]
27. Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients.
Ammar H; Chadli Z; Mhalla A; Khouadja S; Hannachi I; Alshaikheid M; Slama A; Ben Fredj N; Ben Fadhel N; Ben Romdhane H; Chaabane A; Boughattas NA; Gaha L; Zarrouk L; Aouam K
Pharmacogenomics J; 2021 Oct; 21(5):551-558. PubMed ID: 33731885
[TBL] [Abstract][Full Text] [Related]
28. Effects of Vitamin D Receptor, Cytochrome P450 3A, and Cytochrome P450 Oxidoreductase Genetic Polymorphisms on the Pharmacokinetics of Remimazolam in Healthy Chinese Volunteers.
Hu K; Xiang Q; Wang Z; Sheng X; Li L; Liang Y; Zhao X; Ye X; Cui Y
Clin Pharmacol Drug Dev; 2021 Jan; 10(1):22-29. PubMed ID: 32250057
[TBL] [Abstract][Full Text] [Related]
29. CYP1A2 Genotype Variations Do Not Modify the Benefits and Drawbacks of Caffeine during Exercise: A Pilot Study.
Salinero JJ; Lara B; Ruiz-Vicente D; Areces F; Puente-Torres C; Gallo-Salazar C; Pascual T; Del Coso J
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28287486
[TBL] [Abstract][Full Text] [Related]
30. CYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study.
Song YL; Wang L; Ren JC; Xu ZH
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173252
[TBL] [Abstract][Full Text] [Related]
31. CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine.
Viikki M; Kampman O; Seppälä N; Mononen N; Lehtimäki T; Leinonen E
BMC Psychiatry; 2014 Feb; 14():50. PubMed ID: 24555493
[TBL] [Abstract][Full Text] [Related]
32. The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism.
Hilli J; Korhonen T; Turpeinen M; Hokkanen J; Mattila S; Laine K
J Clin Pharmacol; 2008 Aug; 48(8):986-94. PubMed ID: 18490497
[TBL] [Abstract][Full Text] [Related]
33. CYP1A2 rs762551 polymorphism contributes to risk of lung cancer: a meta-analysis.
Ma Z; Guo W; Gong T; Niu HJ; Wang RW; Jiang YG
Tumour Biol; 2014 Mar; 35(3):2253-7. PubMed ID: 24293373
[TBL] [Abstract][Full Text] [Related]
34. The effect of CYP1A2 genotype on the ergogenic properties of caffeine during resistance exercise: a randomized, double-blind, placebo-controlled, crossover study.
Rahimi R
Ir J Med Sci; 2019 Feb; 188(1):337-345. PubMed ID: 29532291
[TBL] [Abstract][Full Text] [Related]
35. Contribution of CYP19A1, CYP1A1, and CYP1A2 polymorphisms in coronary heart disease risk among the Chinese Han population.
Ye W; Tang Q; Wang L; Fang C; Xie L; He Q; Peng K
Funct Integr Genomics; 2022 Aug; 22(4):515-524. PubMed ID: 35380334
[TBL] [Abstract][Full Text] [Related]
36. Comparison of linkage disequilibrium patterns and haplotype structure of eight single nucleotide polymorphisms across the CYP1A2 gene between the Korean, and other populations registered in the International HapMap database.
Woo SW; Kang TS; Park HJ; Lee JE; Roh J
J Clin Pharm Ther; 2009 Aug; 34(4):429-36. PubMed ID: 19583676
[TBL] [Abstract][Full Text] [Related]
37. Association of CYP19A1 and CYP1A2 genetic polymorphisms with type 2 diabetes mellitus risk in the Chinese Han population.
Yang Y; Wang P
Lipids Health Dis; 2020 Aug; 19(1):187. PubMed ID: 32814585
[TBL] [Abstract][Full Text] [Related]
38. The CYP1A2 -163C>A polymorphism does not alter the effects of caffeine on basketball performance.
Puente C; Abián-Vicén J; Del Coso J; Lara B; Salinero JJ
PLoS One; 2018; 13(4):e0195943. PubMed ID: 29668752
[TBL] [Abstract][Full Text] [Related]
39. Effects of
Muñoz A; López-Samanes Á; Aguilar-Navarro M; Varillas-Delgado D; Rivilla-García J; Moreno-Pérez V; Del Coso J
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32823594
[TBL] [Abstract][Full Text] [Related]
40. Associations between Rs4244285 and Rs762551 gene polymorphisms and age-related macular degeneration.
Stasiukonyte N; Liutkeviciene R; Vilkeviciute A; Banevicius M; Kriauciuniene L
Ophthalmic Genet; 2017; 38(4):357-364. PubMed ID: 28095090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
